The results demonstrated that 6 genes are closely associated with the prognosis of RCC patients, including SLC16A12, SLC2A9, IGF2BP2, EMX2, ANK3, and METTL7A. This evidence concerns the gene SLC2A9 and renal cell carcinoma.